SIETES :: 92571 citas

Resultados de la búsqueda por REVISIÓN REFINAR BÚSQUEDA

1.

Navarese EP, Robinson JG, Kowatewski M, Kotodziejczak M, Andreotti F, Bliden K, Tantry U, Kubica J, Raggi P, Gurbel PA. Association between baseline LDL-C level and total and cardiovascular mortality after LDL-C lowering. A systematic review and meta-analysis. JAMA 2018;319:17 de abril. [Ref.ID 102784]

2.

Navar AM, Peterson ED. Challenges in interpreting the lipid-lowering trials: biology vs ecology. JAMA 2018;319:17 de abril. [Ref.ID 102783]

3.

Wallach JD, Ross JS. Gabapentin approvals, off-label use, and lessons for postmarketing evaluation efforts. JAMA 2018;319:27 de febrero. [Ref.ID 102781]

4.

Moore A, Derry S, Wiffen P. Gabapentin for chronic neuropathic pain. JAMA 2018;319:27 de febrero. [Ref.ID 102777]

5.

Coustan DR, Barbour L. Insulin vs glyburide for gestational diabetes. JAMA 2018;319:1 de junio. [Ref.ID 102765]

6.

Anónimo. Pneumonies communautaires peu graves chez les enfants. Prescrire 2018;38:518-23. [Ref.ID 102764]

7.

Anónimo. Gadolinium, IRM et grossesse: des risques pour l'enfant à naître. Prescrire 2018;38:513-5. [Ref.ID 102762]

8.

Anónimo. Atézolizumab et cancer bronchique métastasté ou inopérable. Prescrire 2018;38:503-4. [Ref.ID 102758]

9.

Anónimo. Inotuzumab ozogamicine et leucémie aiguë lymphoblastique chez les adultes. Prescrire 2018;38:494-9. [Ref.ID 102757]

10.

Blankestijn PJ, Bots ML. Renal denervation in uncontrolled hypertension: the story continues to unfold. Lancet 2018;391:9 de junio. [Ref.ID 102690]

11.

Braillon A, Bewley S. Prescribing in pregnancy shows the weaknesses in pharmacovigilance. BMJ 2018;361:29 de mayo. [Ref.ID 102683]

12.

Angus-Leppan H, Liu RSN. Weighing the risks of valproate in women who could become pregnant. BMJ 2018;361:18 de abril. [Ref.ID 102682]

13.

Sobieraj DM, Weeda ER, Nguyen E, Coleman CI, White M, Lazarus SC, Blake KV, Lang JE, Baker WL. Association of inhaled corticosteroids and long-acting ß-agonists as controller and quick relief therapy with exacerbations and symptom control in persistent asthma. A systematic review and meta-analysis. JAMA 2018;319:10 de abril. [Ref.ID 102671]

14.

Sobieraj DM, Baker WL, Nguyen E, Weeda ER, Coleman CI, White CM, Lazarus SC, Blake KV, Lang JE. Association of inhaled corticosteroids and long-acting muscarinic antagonists with asthma control in patients with uncontrolled, persistent asthma. A systematic review and meta-analysis. JAMA 2018;319:10 de abril. [Ref.ID 102670]

15.

16.

Ramaekers JG. Driving under the influence of cannabis. An increasing public health concern. JAMA 2018;319:10 de abril. [Ref.ID 102668]

17.

Anónimo. Conjonctivites présumées bactériennes. Prescrire 2018;38:361-5. [Ref.ID 102660]

18.

Anónimo. Alectinib et cancers bronchiques ALK-positifs. Prescrire 2018;38:337-9. [Ref.ID 102653]

19.

Anónimo. Acide obéticholique et cholangite biliaire primitive. Prescrire 2018;38:326-7. [Ref.ID 102652]

20.

Yong HY, McKay KA, Daley CGJ, Tremlett H. Drug exposure and the risk of multiple sclerosis: a systematic review. Pharmacoepidemiol Drug Saf 2018;27:febrero. [Ref.ID 102630]